Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease
V Khanijou, N Zafari, MT Coughlan… - Diabetes/Metabolism …, 2022 - Wiley Online Library
Diabetic kidney disease is expected to increase rapidly over the coming decades with rising
prevalence of diabetes worldwide. Current measures of kidney function based on …
prevalence of diabetes worldwide. Current measures of kidney function based on …
Advances in the progression and prognosis biomarkers of chronic kidney disease
Z Yan, G Wang, X Shi - Frontiers in Pharmacology, 2021 - frontiersin.org
Chronic kidney disease (CKD) is one of the increasingly serious public health concerns
worldwide; the global burden of CKD is increasingly due to high morbidity and mortality. At …
worldwide; the global burden of CKD is increasingly due to high morbidity and mortality. At …
Quercetin improves lipid metabolism via SCAP-SREBP2-LDLr signaling pathway in early stage diabetic nephropathy
X Jiang, J Yu, X Wang, J Ge, N Li - Diabetes, Metabolic Syndrome …, 2019 - Taylor & Francis
Purpose: Quercetin, the most widely distributed flavonoid, has been shown to have multiple
properties and beneficial effects on various metabolic diseases. Thus, our aim was to …
properties and beneficial effects on various metabolic diseases. Thus, our aim was to …
[HTML][HTML] Interleukin 37 (IL-37) reduces high glucose-induced inflammation, oxidative stress, and apoptosis of podocytes by inhibiting the STAT3–cyclophilin a (CypA) …
X Zhang, Y Zhu, Y Zhou, B Fei - Medical Science Monitor …, 2020 - ncbi.nlm.nih.gov
Background Diabetic nephropathy (DN), the formation of albuminuria, is one of the most
important complications seen in diabetic patients. IL-37, an inhibitor of congenital …
important complications seen in diabetic patients. IL-37, an inhibitor of congenital …
Prognostic impacts of plasma levels of cyclophilin A in patients with coronary artery disease
T Ohtsuki, K Satoh, J Omura, N Kikuchi… - … , and vascular biology, 2017 - Am Heart Assoc
Objective—Cyclophilin A (CyPA) is secreted from vascular smooth muscle cells,
inflammatory cells, and activated platelets in response to oxidative stress. We have recently …
inflammatory cells, and activated platelets in response to oxidative stress. We have recently …
Renoprotective effects of oleanolic acid and its possible mechanisms in rats with diabetic kidney disease
Y Liu, Z Hu, H Xing, L Kang, X Chen, B Liu… - … and Biophysical Research …, 2022 - Elsevier
Dyslipidemia and inflammation have great roles in the development of diabetic nephropathy
(DN). Oleanolic acid (OA) is a natural triterpenoid that possesses multiple pharmacological …
(DN). Oleanolic acid (OA) is a natural triterpenoid that possesses multiple pharmacological …
Cyclophilin A promotes inflammation in acute kidney injury but not in renal fibrosis
KG Leong, E Ozols, J Kanellis… - International journal of …, 2020 - mdpi.com
Cyclophilin A (CypA) is a highly abundant protein in the cytoplasm of most mammalian cells.
Beyond its homeostatic role in protein folding, CypA is a Damage-Associated Molecular …
Beyond its homeostatic role in protein folding, CypA is a Damage-Associated Molecular …
Evaluation of the therapeutic effects of protocatechuic aldehyde in diabetic nephropathy
YT Chang, MC Chung, CC Hsieh, JJ Shieh, MJ Wu - Toxins, 2021 - mdpi.com
Diabetic nephropathy (DN) is one of the most severe chronic kidney diseases in diabetes
and is the main cause of end-stage renal disease (ESRD). Protocatechuic aldehyde (PCA) …
and is the main cause of end-stage renal disease (ESRD). Protocatechuic aldehyde (PCA) …
Cyclophilin A and CD147 associate with progression of diabetic nephropathy
PF Chiu, SL Su, CC Tsai, CL Wu, CL Kuo… - Free radical …, 2018 - Taylor & Francis
To find the associations of circulating cyclophilin A (CyP A) and CD147/EMMPRIN with renal
outcomes in type 2 diabetes patients and possible pathogenesis involved. Total 131 patients …
outcomes in type 2 diabetes patients and possible pathogenesis involved. Total 131 patients …
Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes
NAB Salem, RM El Helaly, IM Ali… - Pediatric …, 2020 - Wiley Online Library
Background Currently, microalbuminuria is the gold standard for detection and prediction of
diabetic nephropathy (DN). However, microalbuminuria appears once significant kidney …
diabetic nephropathy (DN). However, microalbuminuria appears once significant kidney …